What Is the Prognosis for Patients Taking Imatinib?
The prognosis for patients with CML and GISTs has significantly improved with the introduction of imatinib. Many patients achieve complete remission and have long-term survival. However, some patients may develop resistance to the drug, necessitating alternative treatments or combination therapies.